pillbase.ru

Guanfacine

Active substance: guanfacine

TABLET, EXTENDED RELEASE · GUANFACINE HYDROCHLORIDE 4 mg/1

United StatesActive

Marketing holder: Sun Pharmaceutical Industries, Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Эстулик
    таблетки, 1 мг (original in Russian, GRLS)
    П N014629/01
    ЗАО "Фармацевтический завод ЭГИС"
EU 2
  • Intuniv
    guanfacine hydrochloride
    EMEA/H/C/003759
    Takeda Pharmaceuticals International AG Ireland
  • Paxneury
    guanfacine hydrochloride
    EMEA/H/C/006312
    Neuraxpharm Pharmaceuticals S.L.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c5-8961-7a1c-9f10-51b4c1fb6666;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2962-7136-a9bc-70224f9fc4e4,01a1208c-2b16-7263-adc0-eff9ca856390,01a1208c-2b45-705a-a201-4203b864e1bd,01a1208c-2e6e-754c-b8a3-3dbd1b5952a9,01a1208c-30b7-7eaf-9f56-c1cb65350328;count=123 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
63304-927
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 63304-927 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 63304-927 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 63304-927 · Verified 2026-10-09 · open in source